What is an advantage of the attenuated vaccine form?

What is an advantage of the attenuated vaccine form?

• A. It can be used in immunocompromised patients.
• B. It induces both humoral and cell-mediated immunity.
• C. There is no interference of maternal antibodies in infants.
• D. It does not require special handling and storage to maintain its effectiveness.

Answer: (B)

Live attenuated vaccines replicate in the body, which makes the immune system respond as if a real infection were occurring. This replication leads to antigen presentation in multiple ways: extracellular antigens stimulate B cells and antibody production (humoral immunity), while intracellular antigen production in infected cells presents on MHC class I molecules to CD8+ T cells, creating a strong cell-mediated response. The combination of these two arms also promotes durable memory for both antibodies and T cells, often after fewer doses than non-replicating vaccines. That breadth and durability—antibody production plus robust T-cell responses—is what makes this vaccine form advantageous. While this type can be highly effective, it’s not ideal for everyone. Immunocompromised individuals may be at risk from even a weakened organism; maternal antibodies in infants can sometimes neutralize the vaccine before it provokes a full response; and these vaccines typically require careful cold-chain handling to maintain potency, not easy, always simple storage.

Live attenuated vaccines replicate in the body, which makes the immune system respond as if a real infection were occurring. This replication leads to antigen presentation in multiple ways: extracellular antigens stimulate B cells and antibody production (humoral immunity), while intracellular antigen production in infected cells presents on MHC class I molecules to CD8+ T cells, creating a strong cell-mediated response. The combination of these two arms also promotes durable memory for both antibodies and T cells, often after fewer doses than non-replicating vaccines. That breadth and durability—antibody production plus robust T-cell responses—is what makes this vaccine form advantageous.

While this type can be highly effective, it’s not ideal for everyone. Immunocompromised individuals may be at risk from even a weakened organism; maternal antibodies in infants can sometimes neutralize the vaccine before it provokes a full response; and these vaccines typically require careful cold-chain handling to maintain potency, not easy, always simple storage.